Charlotte's Web Holdings (CWBHF) Income from Continuing Operations (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Income from Continuing Operations came in at 13112000.0 in Q1 2026, down 111.08% year-on-year from 118389162.79 in Q1 2025, and down 14.79% on a QoQ basis from 11423000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Income from Continuing Operations data on file, last reported at 13112000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 111.08% year-over-year to 13112000.0 in Q1 2026; TTM through Mar 2026 was 36641000.0, a 38.67% decrease from a year earlier, with the FY2025 full-year figure at 29741000.0, changed 0.35% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 13112000.0, down from 11423000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for CWBHF reached as high as 2844000.0 in Q2 2023 and fell as low as 35229000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 9165176.47 across 5 years, with a median of 7870000.0 in 2022.
- Across the five-year window, Income from Continuing Operations tumbled 876.58% in 2022 and soared 136.14% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 35229000.0 in 2022, then jumped by 75.63% to 8585000.0 in 2023, then soared by 60.77% to 3368000.0 in 2024, then plunged by 239.16% to 11423000.0 in 2025, then dropped by 14.79% to 13112000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 13112000.0 in Q1 2026, 11423000.0 in Q4 2025, and 5818000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -13.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -11.42 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -6.21 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -11.06 Mn |
| Mar 31, 2024 | -9.63 Mn |
| Dec 31, 2023 | -8.59 Mn |
| Sep 30, 2023 | -15.14 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | -35.23 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -118.25 Mn |
| Sep 30, 2021 | -777,000.00 |
| Jun 30, 2021 | -5.92 Mn |